Robert P. Hartman

Robert P. Hartman

Auto-generated profile, based on publicly available information

Robert P. Hartman

Department of Radiology, Mayo Clinic College of Medicine Rochester MN, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2009 in European Radiology
Verified
Journal Article
Closed access
PDF file
CBC. L. Brown
C. L. Brown
RHR. P. Hartman
R. P. Hartman
ODO. P. Dzyubak
O. P. Dzyubak
NTN. Takahashi
N. Takahashi
AKA. Kawashima
A. Kawashima
JFJ. G. Fletcher
J. G. Fletcher

1 March 2012 in Radiologic Clinics of North America
Verified
Journal Article
Closed access
RHRobert Hartman
Robert Hartman
AKAkira Kawashima
Akira Kawashima
NTNaoki Takahashi
Naoki Takahashi
ASAlvin Silva
Alvin Silva
TVTerri Vrtiska
Terri Vrtiska
CMCynthia McCollough
Cynthia McCollough

1 October 2021 in Radiology
Verified
Journal Article
Closed access
JMJennifer S. McDonald
Jennifer S. McDonald
Nicholas B LarsonNicholas B Larson
Nicholas B Larson
AKAmy B. Kolbe
Amy B. Kolbe
CHChristopher Harker Hunt
Christopher Harker Hunt
JSJohn Joseph Schmitz
John Joseph Schmitz
RMRobert J. McDonald
Robert J. McDonald
The study findings do not support the efficacy of steroid premedication (oral methylprednisolone at 12 and 2 hours) for preventing repeat allergic-like reactions in high-risk patients. Background It is unclear whether steroid premedication is an effective means of preventing repeat allergic-like reactions in high-risk patients with a previous allergic-like reaction to iodinated c...

24 February 2016 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
RHRobert P. Hartman
Robert P. Hartman
AKAkira Kawashima
Akira Kawashima
NTNaoki Takahashi
Naoki Takahashi
ALAndrew J. LeRoy
Andrew J. LeRoy
BKBernard F. King
Bernard F. King

16 March 2023 in Mayo Clinic Proceedings
Verified
Journal Article
Open access
TPTheodora A. Potretzke
Theodora A. Potretzke
PKPanagiotis Korfiatis
Panagiotis Korfiatis
DBDaniel J. Blezek
Daniel J. Blezek
MEMarie E. Edwards
Marie E. Edwards
JKJason R. Klug
Jason R. Klug
TKTimothy L. Kline
Timothy L. Kline
To evaluate the performance of an internally developed and previously validated artificial intelligence (AI) algorithm for magnetic resonance (MR)-derived total kidney volume (TKV) in autosomal dominant polycystic kidney disease (ADPKD) when implemented in clinical practice. The study included adult patients with ADPKD seen by a nephrologist at our institution between November 2019 and January 2021 and undergoing an MR imaging examination as part of standard clinical care. Thirty-three nephrologists ordered MR imaging, requesting AI-based TKV calculation for 170 cases in these 161 unique patients. We tracked implementation and performance of the algorithm over 1 year. A radiologist and a radiology technologist reviewed all cases (N=170) for quality and accuracy. Manual editing of algorithm output occurred at radiology or radiology technologist discretion. Performance was assessed by comparing AI-based and manually edited segmentations via measures of similarity and dissimilarity to ensure expected performance. We analyzed ADPKD severity class assignment of algorithm-derived vs manually edited TKV to assess impact. Clinical implementation was successful. Artificial intelligence algorithm-based segmentation showed high levels of agreement and was noninferior to interobserver variability and other methods for determining TKV. Of manually edited cases (n=84), the AI-algorithm TKV output showed a small mean volume difference of -3.3%. Agreement for disease class between AI-based and manually edited segmentation was high (five cases differed). Performance of an AI algorithm in real-life clinical practice can be preserved if there is careful development and validation and if the implementation environment closely matches the development conditions.

1 January 2013 in Journal of Computer Assisted Tomography
Verified
Journal Article
Closed access
AFAdam T. Froemming
Adam T. Froemming
AKAkira Kawashima
Akira Kawashima
NTNaoki Takahashi
Naoki Takahashi
RHRobert P. Hartman
Robert P. Hartman
MNMark A. Nathan
Mark A. Nathan
JFJoel G. Fletcher
Joel G. Fletcher
Objective The objective of this study was to analyze radiation dose reduction and image quality by combining automated kV selection, tube current reduction, and iterative reconstruction. Methods This was a retrospective analysis of the excretory phase of 55 patients with 2 computed tomography urography examinations: automated kV selection with tube current reduction (“low-dose protocol”: with filtered back projection vs iterative reconstruction) and routine dose examinations. Image quality was analyzed blindly and in side-by-side analyses, in addition to quantitative measurements. Results Low-dose protocol median dose change was −40% (−10.7 to +12.9 mGy); 100 kV was autoselected in 44 (80%) of 55 patients (body mass index range, 19–36 kg/m2) with mean dose reduction of 42.5%. Whereas up to 19% of low-dose images with filtered back projection were inferior by blinded review (P < 0.001), low-dose iterative reconstruction images were not rated inferior (P = 1.0). Conclusions The combination of iterative reconstruction, automated kV selection, and tube current reduction results in radiation dose reduction with preserved image quality and diagnostic confidence.